Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 11/2022

25-08-2022 | Crohn's Disease | Original Article

The Prevalence of Concomitant Skip Small Bowel Lesions in Crohn’s Disease and Their Effects on Reoperation in Patients Undergoing Ileocolic Resection

Authors: Wenwei Qian, Lei Gao, Liangyu Huang, Zhen Guo, Lei Cao, Jianfeng Gong, Yi Li, Weiming Zhu

Published in: Journal of Gastrointestinal Surgery | Issue 11/2022

Login to get access

Abstract

Aims

Concomitant lesions in the small intestine are common in Crohn’s disease (CD). This study aimed to detect the incidence of small bowel (SB) lesions in patients undergoing surgical resection for symptomatic ileocolic disease and whether concomitant SB lesions are associated with reoperation due to recurrent CD.

Methods

In this observational, historical cohort study, consecutive patients with CD undergoing primary ileocolic resection (ICR) from 2007 to 2019 were included. Clinical variables and intraoperative findings were extracted from a prospectively maintained database and analyzed by Cox proportional hazards regression models for identifying risk factors of reoperation.

Results

Of the 404 patients included, there were 202 (50%) patients having concomitant SB lesions, and 108 of them underwent concurrent surgical intervention for SB lesions whereas 94 did not. The presence of concomitant SB lesions was a risk factor for reoperation (p = 0.041). Subgroup analysis indicated that patients with concomitant uncomplicated SB lesions left in situ had a comparable rate of reoperation (p = 0.605) whereas patients having concomitant complicated SB lesions undergoing simultaneous surgical intervention showed a higher reoperation rate (P = 0.006) when compared with those without concomitant SB lesions. Interestingly, the adverse effects of concomitant SB lesions can be reversed in the setting of postoperative anti-TNF agents [HR 0.2; 95% CI (0.04–0.9); P=0.040].

Conclusions

Concomitant SB lesion(s), especially those complicated lesions, could be a risk factor for postoperative surgical recurrence in patients undergoing ICR. Active postoperative management strategies such as anti-TNF agents should be provided for these patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference N.A. Molodecky, I.S. Soon, D.M. Rabi, W.A. Ghali, M. Ferris, G. Chernoff, E.I. Benchimol, R. Panaccione, S. Ghosh, H.W. Barkema, and G.G. Kaplan. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 142:46-54.e42; quiz e30 (2012).CrossRefPubMed N.A. Molodecky, I.S. Soon, D.M. Rabi, W.A. Ghali, M. Ferris, G. Chernoff, E.I. Benchimol, R. Panaccione, S. Ghosh, H.W. Barkema, and G.G. Kaplan. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 142:46-54.e42; quiz e30 (2012).CrossRefPubMed
2.
go back to reference J.J. Zheng, X.S. Zhu, Z. Huangfu, X.H. Shi, and Z.R. Guo. Prevalence and incidence rates of Crohn’s disease in mainland China: a meta-analysis of 55 years of research. J Dig Dis. 11:161-166 (2010).CrossRefPubMed J.J. Zheng, X.S. Zhu, Z. Huangfu, X.H. Shi, and Z.R. Guo. Prevalence and incidence rates of Crohn’s disease in mainland China: a meta-analysis of 55 years of research. J Dig Dis. 11:161-166 (2010).CrossRefPubMed
3.
go back to reference S.K. Murthy, J. Begum, E.I. Benchimol, C.N. Bernstein, G.G. Kaplan, J.D. McCurdy, H. Singh, L. Targownik, and M. Taljaard. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study. Gut. 69:274-282 (2020).CrossRefPubMed S.K. Murthy, J. Begum, E.I. Benchimol, C.N. Bernstein, G.G. Kaplan, J.D. McCurdy, H. Singh, L. Targownik, and M. Taljaard. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study. Gut. 69:274-282 (2020).CrossRefPubMed
5.
go back to reference A.D. Frolkis, D.S. Lipton, K.M. Fiest, M.E. Negrón, J. Dykeman, J. deBruyn, N. Jette, T. Frolkis, A. Rezaie, C.H. Seow, R. Panaccione, S. Ghosh, and G.G. Kaplan. Cumulative incidence of second intestinal resection in Crohn’s disease: a systematic review and meta-analysis of population-based studies. The American journal of gastroenterology. 109:1739-1748 (2014).CrossRefPubMed A.D. Frolkis, D.S. Lipton, K.M. Fiest, M.E. Negrón, J. Dykeman, J. deBruyn, N. Jette, T. Frolkis, A. Rezaie, C.H. Seow, R. Panaccione, S. Ghosh, and G.G. Kaplan. Cumulative incidence of second intestinal resection in Crohn’s disease: a systematic review and meta-analysis of population-based studies. The American journal of gastroenterology. 109:1739-1748 (2014).CrossRefPubMed
6.
go back to reference J.T. Unkart, L. Anderson, E. Li, C. Miller, Y. Yan, C.C. Gu, J. Chen, C.D. Stone, S. Hunt, and D.W. Dietz. Risk factors for surgical recurrence after ileocolic resection of Crohn’s disease. Diseases of the colon and rectum. 51:1211-1216 (2008).CrossRefPubMedPubMedCentral J.T. Unkart, L. Anderson, E. Li, C. Miller, Y. Yan, C.C. Gu, J. Chen, C.D. Stone, S. Hunt, and D.W. Dietz. Risk factors for surgical recurrence after ileocolic resection of Crohn’s disease. Diseases of the colon and rectum. 51:1211-1216 (2008).CrossRefPubMedPubMedCentral
7.
go back to reference S. Post, C. Herfarth, E. Böhm, G. Timmermanns, H. Schumacher, G. Schürmann, and M. Golling. The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn’s disease. Annals of surgery. 223:253-260 (1996).CrossRefPubMedPubMedCentral S. Post, C. Herfarth, E. Böhm, G. Timmermanns, H. Schumacher, G. Schürmann, and M. Golling. The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn’s disease. Annals of surgery. 223:253-260 (1996).CrossRefPubMedPubMedCentral
8.
go back to reference M.H. Wang, J.J. Friton, L.E. Raffals, J.A. Leighton, S.F. Pasha, M.F. Picco, K. Monroe, B.D. Nix, R.D. Newberry, and W.A. Faubion. Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn’s Disease Patients. Inflammatory bowel diseases. 27:1968-1974 (2021).CrossRefPubMed M.H. Wang, J.J. Friton, L.E. Raffals, J.A. Leighton, S.F. Pasha, M.F. Picco, K. Monroe, B.D. Nix, R.D. Newberry, and W.A. Faubion. Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn’s Disease Patients. Inflammatory bowel diseases. 27:1968-1974 (2021).CrossRefPubMed
9.
go back to reference R. Bolckmans, T. Kalman, S. Singh, K.C. Ratnatunga, P. Myrelid, S. Travis, and B.D. George. Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn’s Disease? Diseases of the colon and rectum. 63:200-206 (2020).CrossRefPubMed R. Bolckmans, T. Kalman, S. Singh, K.C. Ratnatunga, P. Myrelid, S. Travis, and B.D. George. Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn’s Disease? Diseases of the colon and rectum. 63:200-206 (2020).CrossRefPubMed
10.
go back to reference P. Papay, W. Reinisch, E. Ho, C. Gratzer, D. Lissner, H. Herkner, S. Riss, C. Dejaco, W. Miehsler, H. Vogelsang, and G. Novacek. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn’s disease after first intestinal surgery. The American journal of gastroenterology. 105:1158-1164 (2010).CrossRefPubMed P. Papay, W. Reinisch, E. Ho, C. Gratzer, D. Lissner, H. Herkner, S. Riss, C. Dejaco, W. Miehsler, H. Vogelsang, and G. Novacek. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn’s disease after first intestinal surgery. The American journal of gastroenterology. 105:1158-1164 (2010).CrossRefPubMed
11.
go back to reference E. Savarino, G. Bodini, P. Dulbecco, L. Assandri, L. Bruzzone, F. Mazza, A.C. Frigo, V. Fazio, E. Marabotto, and V. Savarino. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. The American journal of gastroenterology. 108:1731-1742 (2013).CrossRefPubMed E. Savarino, G. Bodini, P. Dulbecco, L. Assandri, L. Bruzzone, F. Mazza, A.C. Frigo, V. Fazio, E. Marabotto, and V. Savarino. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. The American journal of gastroenterology. 108:1731-1742 (2013).CrossRefPubMed
12.
go back to reference M. Regueiro, B.G. Feagan, B. Zou, J. Johanns, M.A. Blank, M. Chevrier, S. Plevy, J. Popp, F.J. Cornillie, M. Lukas, S. Danese, P. Gionchetti, S.B. Hanauer, W. Reinisch, W.J. Sandborn, D. Sorrentino, and P. Rutgeerts. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection. Gastroenterology. 150:1568-1578 (2016).CrossRefPubMed M. Regueiro, B.G. Feagan, B. Zou, J. Johanns, M.A. Blank, M. Chevrier, S. Plevy, J. Popp, F.J. Cornillie, M. Lukas, S. Danese, P. Gionchetti, S.B. Hanauer, W. Reinisch, W.J. Sandborn, D. Sorrentino, and P. Rutgeerts. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection. Gastroenterology. 150:1568-1578 (2016).CrossRefPubMed
13.
go back to reference B.P. Kline, T. Weaver, D.L. Brinton, Jr., L. Harris, G.S. Yochum, A.S. Berg, and W.A. Koltun. Clinical and Genetic Factors Impact Time to Surgical Recurrence After Ileocolectomy for Crohn’s Disease. Annals of surgery. 274:346-351 (2021).CrossRefPubMed B.P. Kline, T. Weaver, D.L. Brinton, Jr., L. Harris, G.S. Yochum, A.S. Berg, and W.A. Koltun. Clinical and Genetic Factors Impact Time to Surgical Recurrence After Ileocolectomy for Crohn’s Disease. Annals of surgery. 274:346-351 (2021).CrossRefPubMed
14.
go back to reference G.R. Lichtenstein, E.V. Loftus, K.L. Isaacs, M.D. Regueiro, L.B. Gerson, and B.E. Sands. ACG Clinical Guideline: Management of Crohn’s Disease in Adults. The American journal of gastroenterology. 113:481-517 (2018).CrossRefPubMed G.R. Lichtenstein, E.V. Loftus, K.L. Isaacs, M.D. Regueiro, L.B. Gerson, and B.E. Sands. ACG Clinical Guideline: Management of Crohn’s Disease in Adults. The American journal of gastroenterology. 113:481-517 (2018).CrossRefPubMed
15.
go back to reference F. Michelassi, T. Balestracci, R. Chappell, and G.E. Block. Primary and recurrent Crohn’s disease. Experience with 1379 patients. Annals of surgery. 214:230-238; discussion 238-240 (1991).CrossRefPubMedPubMedCentral F. Michelassi, T. Balestracci, R. Chappell, and G.E. Block. Primary and recurrent Crohn’s disease. Experience with 1379 patients. Annals of surgery. 214:230-238; discussion 238-240 (1991).CrossRefPubMedPubMedCentral
16.
go back to reference J. Kusaka, H. Shiga, M. Kuroha, T. Kimura, Y. Kakuta, K. Endo, Y. Kinouchi, and T. Shimosegawa. Residual Lesions on Capsule Endoscopy Is Associated with Postoperative Clinical Recurrence in Patients with Crohn’s Disease. Dig Dis Sci. 63:768-774 (2018).CrossRefPubMed J. Kusaka, H. Shiga, M. Kuroha, T. Kimura, Y. Kakuta, K. Endo, Y. Kinouchi, and T. Shimosegawa. Residual Lesions on Capsule Endoscopy Is Associated with Postoperative Clinical Recurrence in Patients with Crohn’s Disease. Dig Dis Sci. 63:768-774 (2018).CrossRefPubMed
17.
go back to reference O. Klein, J.F. Colombel, D. Lescut, L. Gambiez, P. Desreumaux, P. Quandalle, and A. Cortot. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn’s disease. The American journal of gastroenterology. 90:1949-1952 (1995).PubMed O. Klein, J.F. Colombel, D. Lescut, L. Gambiez, P. Desreumaux, P. Quandalle, and A. Cortot. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn’s disease. The American journal of gastroenterology. 90:1949-1952 (1995).PubMed
18.
go back to reference F. Gomollón, A. Dignass, V. Annese, H. Tilg, G. Van Assche, J.O. Lindsay, L. Peyrin-Biroulet, G.J. Cullen, M. Daperno, T. Kucharzik, F. Rieder, S. Almer, A. Armuzzi, M. Harbord, J. Langhorst, M. Sans, Y. Chowers, G. Fiorino, P. Juillerat, G.J. Mantzaris, F. Rizzello, S. Vavricka, and P. Gionchetti. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis. 11:3-25 (2017).CrossRefPubMed F. Gomollón, A. Dignass, V. Annese, H. Tilg, G. Van Assche, J.O. Lindsay, L. Peyrin-Biroulet, G.J. Cullen, M. Daperno, T. Kucharzik, F. Rieder, S. Almer, A. Armuzzi, M. Harbord, J. Langhorst, M. Sans, Y. Chowers, G. Fiorino, P. Juillerat, G.J. Mantzaris, F. Rizzello, S. Vavricka, and P. Gionchetti. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis. 11:3-25 (2017).CrossRefPubMed
19.
go back to reference J. Satsangi, M.S. Silverberg, S. Vermeire, and J.F. Colombel. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 55:749-753 (2006).CrossRefPubMedPubMedCentral J. Satsangi, M.S. Silverberg, S. Vermeire, and J.F. Colombel. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 55:749-753 (2006).CrossRefPubMedPubMedCentral
20.
go back to reference P. Gionchetti, A. Dignass, S. Danese, F.J. Magro Dias, G. Rogler, P.L. Lakatos, M. Adamina, S. Ardizzone, C.J. Buskens, S. Sebastian, S. Laureti, G.M. Sampietro, B. Vucelic, C.J. van der Woude, M. Barreiro-de Acosta, C. Maaser, F. Portela, S.R. Vavricka, and F. Gomollon. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations. J Crohns Colitis. 11:135-149 (2017).CrossRefPubMed P. Gionchetti, A. Dignass, S. Danese, F.J. Magro Dias, G. Rogler, P.L. Lakatos, M. Adamina, S. Ardizzone, C.J. Buskens, S. Sebastian, S. Laureti, G.M. Sampietro, B. Vucelic, C.J. van der Woude, M. Barreiro-de Acosta, C. Maaser, F. Portela, S.R. Vavricka, and F. Gomollon. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations. J Crohns Colitis. 11:135-149 (2017).CrossRefPubMed
21.
go back to reference F. Michelassiand S. Sultan. Surgical treatment of complex small bowel Crohn disease. Ann Surg. 260:230-235 (2014).CrossRef F. Michelassiand S. Sultan. Surgical treatment of complex small bowel Crohn disease. Ann Surg. 260:230-235 (2014).CrossRef
22.
go back to reference S. Riss, I. Schuster, P. Papay, F. Herbst, M. Mittlbock, P. Chitsabesan, and A. Stift. Surgical recurrence after primary ileocolic resection for Crohn’s disease. Tech Coloproctol. 18:365-371 (2014).CrossRefPubMed S. Riss, I. Schuster, P. Papay, F. Herbst, M. Mittlbock, P. Chitsabesan, and A. Stift. Surgical recurrence after primary ileocolic resection for Crohn’s disease. Tech Coloproctol. 18:365-371 (2014).CrossRefPubMed
23.
go back to reference C. Simillis, T. Yamamoto, G.E. Reese, S. Umegae, K. Matsumoto, A.W. Darzi, and P.P. Tekkis. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am J Gastroenterol. 103:196-205 (2008).CrossRefPubMed C. Simillis, T. Yamamoto, G.E. Reese, S. Umegae, K. Matsumoto, A.W. Darzi, and P.P. Tekkis. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am J Gastroenterol. 103:196-205 (2008).CrossRefPubMed
24.
go back to reference O. Bernell, A. Lapidus, and G. Hellers. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn’s disease. Br J Surg. 87:1697-1701 (2000).CrossRefPubMed O. Bernell, A. Lapidus, and G. Hellers. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn’s disease. Br J Surg. 87:1697-1701 (2000).CrossRefPubMed
25.
go back to reference S.B. Kim, J.H. Cheon, J.J. Park, E.S. Kim, S.W. Jeon, S.A. Jung, D.I. Park, C.K. Lee, J.P. Im, Y.S. Kim, H.S. Kim, J. Lee, C.S. Eun, J.M. Lee, B.I. Jang, G.S. Seo. Risk factors for postoperative recurrence in Korean patients with Crohn’s disease. Gut Liver. 14(3):331-337 (2020).CrossRefPubMed S.B. Kim, J.H. Cheon, J.J. Park, E.S. Kim, S.W. Jeon, S.A. Jung, D.I. Park, C.K. Lee, J.P. Im, Y.S. Kim, H.S. Kim, J. Lee, C.S. Eun, J.M. Lee, B.I. Jang, G.S. Seo. Risk factors for postoperative recurrence in Korean patients with Crohn’s disease. Gut Liver. 14(3):331-337 (2020).CrossRefPubMed
26.
go back to reference L. Maggiori, A. Brouquet, P. Zerbib, J.H. Lefevre, Q. Denost, A. Germain, E. Cotte, L. Beyer-Berjot, N. Munoz-Bongrand, V. Desfourneaux, A. Rahili, J.P. Duffas, K. Pautrat, C. Denet, V. Bridoux, G. Meurette, J.L. Faucheron, J. Loriau, R. Souche, E. Vicaut, Y. Panis, and S. Benoist. Penetrating Crohn Disease Is Not Associated With a Higher Risk of Recurrence After Surgery: A Prospective Nationwide Cohort Conducted by the Getaid Chirurgie Group. Ann Surg. 270:827-834 (2019).CrossRefPubMed L. Maggiori, A. Brouquet, P. Zerbib, J.H. Lefevre, Q. Denost, A. Germain, E. Cotte, L. Beyer-Berjot, N. Munoz-Bongrand, V. Desfourneaux, A. Rahili, J.P. Duffas, K. Pautrat, C. Denet, V. Bridoux, G. Meurette, J.L. Faucheron, J. Loriau, R. Souche, E. Vicaut, Y. Panis, and S. Benoist. Penetrating Crohn Disease Is Not Associated With a Higher Risk of Recurrence After Surgery: A Prospective Nationwide Cohort Conducted by the Getaid Chirurgie Group. Ann Surg. 270:827-834 (2019).CrossRefPubMed
27.
go back to reference S. Shivananda, M.L. Hordijk, A.S. Pena, and J.F. Mayberry. Crohn’s disease: risk of recurrence and reoperation in a defined population. Gut. 30:990-995 (1989).CrossRefPubMedPubMedCentral S. Shivananda, M.L. Hordijk, A.S. Pena, and J.F. Mayberry. Crohn’s disease: risk of recurrence and reoperation in a defined population. Gut. 30:990-995 (1989).CrossRefPubMedPubMedCentral
28.
go back to reference J.D. Feuersteinand A.S. Cheifetz. Crohn Disease: Epidemiology, Diagnosis, and Management. Mayo Clin Proc. 92:1088-1103 (2017).CrossRef J.D. Feuersteinand A.S. Cheifetz. Crohn Disease: Epidemiology, Diagnosis, and Management. Mayo Clin Proc. 92:1088-1103 (2017).CrossRef
29.
go back to reference M. Regueiro, W. Schraut, L. Baidoo, K.E. Kip, A.R. Sepulveda, M. Pesci, J. Harrison, and S.E. Plevy. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology. 136:441-450.e441; quiz 716 (2009).CrossRefPubMed M. Regueiro, W. Schraut, L. Baidoo, K.E. Kip, A.R. Sepulveda, M. Pesci, J. Harrison, and S.E. Plevy. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology. 136:441-450.e441; quiz 716 (2009).CrossRefPubMed
30.
go back to reference T.Y. Zhang, Y. Lin, R. Fan, S.R. Hu, M.M. Cheng, M.C. Zhang, L.W. Hong, X.L. Zhou, Z.T. Wang, and J. Zhong. Potential model for differential diagnosis between Crohn’s disease and primary intestinal lymphoma. World J Gastroenterol. 22:9411-9418 (2016).CrossRefPubMedPubMedCentral T.Y. Zhang, Y. Lin, R. Fan, S.R. Hu, M.M. Cheng, M.C. Zhang, L.W. Hong, X.L. Zhou, Z.T. Wang, and J. Zhong. Potential model for differential diagnosis between Crohn’s disease and primary intestinal lymphoma. World J Gastroenterol. 22:9411-9418 (2016).CrossRefPubMedPubMedCentral
31.
go back to reference J. Kusakaand H. Shiga. Residual Lesions on Capsule Endoscopy Is Associated with Postoperative Clinical Recurrence in Patients with Crohn’s Disease. 63:768-774 (2018). J. Kusakaand H. Shiga. Residual Lesions on Capsule Endoscopy Is Associated with Postoperative Clinical Recurrence in Patients with Crohn’s Disease. 63:768-774 (2018).
32.
go back to reference W.A. Bemelman, J. Warusavitarne, G.M. Sampietro, Z. Serclova, O. Zmora, G. Luglio, A. de Buck van Overstraeten, J.P. Burke, C.J. Buskens, F. Colombo, J.A. Dias, R. Eliakim, T. Elosua, I.E. Gecim, S. Kolacek, J. Kierkus, K.L. Kolho, J.H. Lefevre, M. Millan, Y. Panis, T. Pinkney, R.K. Russell, C. Shwaartz, C. Vaizey, N. Yassin, and A. D’Hoore. ECCO-ESCP Consensus on Surgery for Crohn’s Disease. Journal of Crohn’s & colitis. 12:1-16 (2018). W.A. Bemelman, J. Warusavitarne, G.M. Sampietro, Z. Serclova, O. Zmora, G. Luglio, A. de Buck van Overstraeten, J.P. Burke, C.J. Buskens, F. Colombo, J.A. Dias, R. Eliakim, T. Elosua, I.E. Gecim, S. Kolacek, J. Kierkus, K.L. Kolho, J.H. Lefevre, M. Millan, Y. Panis, T. Pinkney, R.K. Russell, C. Shwaartz, C. Vaizey, N. Yassin, and A. D’Hoore. ECCO-ESCP Consensus on Surgery for Crohn’s Disease. Journal of Crohn’s & colitis. 12:1-16 (2018).
Metadata
Title
The Prevalence of Concomitant Skip Small Bowel Lesions in Crohn’s Disease and Their Effects on Reoperation in Patients Undergoing Ileocolic Resection
Authors
Wenwei Qian
Lei Gao
Liangyu Huang
Zhen Guo
Lei Cao
Jianfeng Gong
Yi Li
Weiming Zhu
Publication date
25-08-2022
Publisher
Springer US
Keyword
Crohn's Disease
Published in
Journal of Gastrointestinal Surgery / Issue 11/2022
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-022-05436-4

Other articles of this Issue 11/2022

Journal of Gastrointestinal Surgery 11/2022 Go to the issue